E Fund Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $532K | Buy |
3,870
+1,612
| +71% | +$222K | 0.03% | 221 |
|
|
2025
Q1 | $407K | Buy |
2,258
+324
| +17% | +$58.4K | 0.02% | 247 |
|
|
2024
Q4 | $303K | Sell |
1,934
-1,007
| -34% | -$158K | 0.02% | 312 |
|
|
2024
Q3 | $535K | Buy |
2,941
+402
| +16% | +$73.2K | 0.03% | 187 |
|
|
2024
Q2 | $466K | Buy |
2,539
+17
| +0.7% | +$3.12K | 0.03% | 182 |
|
|
2024
Q1 | $449K | Sell |
2,522
-1,973
| -44% | -$351K | 0.03% | 174 |
|
|
2023
Q4 | $558K | Buy |
4,495
+808
| +22% | +$100K | 0.04% | 138 |
|
|
2023
Q3 | $428K | Buy |
3,687
+830
| +29% | +$96.3K | 0.03% | 153 |
|
|
2023
Q2 | $335K | Sell |
2,857
-631
| -18% | -$74K | 0.03% | 203 |
|
|
2023
Q1 | $279K | Buy |
3,488
+260
| +8% | +$20.8K | 0.02% | 238 |
|
|
2022
Q4 | $256K | Sell |
3,228
-363
| -10% | -$28.8K | 0.02% | 256 |
|
|
2022
Q3 | $250K | Sell |
3,591
-217
| -6% | -$15.1K | 0.02% | 264 |
|
|
2022
Q2 | $250K | Buy |
3,808
+797
| +26% | +$52.3K | 0.02% | 263 |
|
|
2022
Q1 | $200K | Buy |
+3,011
| New | +$200K | 0.01% | 298 |
|